Cargando…
Clonal origin of KMT2A wild-type lineage-switch leukemia following CAR-T cell and blinatumomab therapy
Children with acute lymphoblastic leukemia (ALL) undergoing anti-CD19 therapy occasionally develop acute myeloid leukemia (AML). The clonal origin of such lineage-switch leukemias(1–4) remains unresolved. Here, we reconstructed the phylogeny of multiple leukemias in a girl who, following multiply re...
Autores principales: | Coorens, Tim H. H., Collord, Grace, Treger, Taryn D., Adams, Stuart, Mitchell, Emily, Newman, Barbara, Getz, Gad, Godfrey, Anna L., Bartram, Jack, Behjati, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447231/ https://www.ncbi.nlm.nih.gov/pubmed/37474833 http://dx.doi.org/10.1038/s43018-023-00604-0 |
Ejemplares similares
-
Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia
por: Khabirova, Eleonora, et al.
Publicado: (2022) -
Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
por: Haddox, C L, et al.
Publicado: (2017) -
Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies
por: Jacoby, Elad
Publicado: (2019) -
Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia
por: He, Rui R., et al.
Publicado: (2019) -
PAX5 alterations in an infant case of KMT2A‐rearranged leukemia with lineage switch
por: Nakajima, Koji, et al.
Publicado: (2022)